Asia Pacific Drug Screening Market Research Report - Segmented By Sample Type, End-user, Products And Services & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC) - Industry Analysis, Size, Share, Trends and Growth Forecast (2024 to 2032)

Updated On: June, 2024
ID: 7850
Pages: 130

Asia Pacific Drug Screening Market Size (2024 to 2032)

The size of the Asia Pacific drug screening market was worth USD 1.15 billion in 2023. The Asia Pacific market is anticipated to grow at a CAGR of 10.8% from 2024 to 2032 and be worth USD 2.88 billion by 2032 from USD 1.27 billion in 2024.

MARKET SCENARIO

Drug screening, otherwise known as drug testing, is performed in various cases, such as when patients are unconscious and cannot tell what drug they have taken earlier. Drug tests are also done for patients to identify which drugs they are allergic to and in cases of known drug allergic conditions with pain management. The testing process involves collecting various samples, including skin, hair follicles, blood, saliva, and urine.

Various factors, including increased population, increased medicine, healthcare, infrastructure, rise in chronic diseases, and rise in intake of drugs by patients, contribute to the growth of the drug screening market. The increase in patients who are allergic to some compositions of drugs also increases market size. For various religious reasons, the ban on substances and drugs is seen. For instance, different Indian regions follow some religious practices where the intake of the drug is considered a sin. In such cases, the drug screening process is performed in terms of substance abuse. People in this region are more aware of drug screening policy increases market size. Growing demand for safety rules and regulations in every place and increasing drug, alcohol, and substance abuse are significant growth driving factors for the drug screening market in developed regions like India, China, and other parts of Asia. Government initiatives for a ban on drugs of abuse and an increase in fundraising activities and awareness of healthy lifestyle activities positively impact the market and increase the market growth.

However, factors such as masking agents' availability to mask drug screening tests are a significant concern for drug screening tests. According to a few regional authorities, drug testing, or drug screening in those particular regions is considered against their privacy policies and violations. Many devices like alcohol screening devices and other devices used in the process of drug testing; should meet standards set up by approval committees. A lot of accuracy issues are noted in recent times for these devices. Devices such as breath analyzers, sample collection devices need to be available at the right time, and these devices' functioning is to be adequately checked to avoid errors in testing.

SEGMENTAL ANALYSIS

Asia Pacific Drug Screening Market Analysis By Sample Type

  • Hair
  • Blood
  • Urine
  • Others

Asia Pacific Drug Screening Market Analysis By End-user

  • Hospitals
  • Workplaces
  • Criminal Justice
  • Law Enforcement

Asia Pacific Drug Screening Market Analysis By Products And Services

  • Breathalyser
  • Rapid Test Device
  • Immunoassay Analyser
  • Chromatography
  • Others

GEOGRAPHICAL ANALYSIS

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The Asia-Pacific regions consist of big and developing countries like India and China. The area is characteristic of increasing levels of personal disposable income. It is making many people subscribe to the usage and abuse of several illegal substances in the area. It is the chief factor behind the very high projected CAGR for the market in the future.

The drug screening market in the Asia Pacific region is further expecting a hike due to various factors such as a rise in patients who are allergic to some compositions of drugs, increased population, increased medicine, and healthcare, infrastructure, an increase of chronic diseases, and a rise in intake of drugs by patients. India and China are the regions with the highest market revenue amongst Asia pacific regions. This due to the highest population, increased substance, and drug abuse in these regions.

KEY MARKET PLAYERS

The Top companies leading in the APAC Drug Screening Market profiled in the report are Thermo Fisher Scientific Inc., Express Diagnostics Int’l Inc., Abbott Laboratories, Siemens AG, Alere Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Biorad Laboratories Inc., Shimadzu and Omega Laboratories.

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample